spacer
spacer

PDBsum entry 1dy1

Go to PDB code: 
Top Page protein metals links
Angiogenesis inhibitor PDB id
1dy1
Contents
Protein chain
183 a.a. *
Metals
_ZN ×2
Waters ×47
* Residue conservation analysis

References listed in PDB file
Key reference
Title Variable zinc coordination in endostatin.
Authors E.Hohenester, T.Sasaki, K.Mann, R.Timpl.
Ref. J Mol Biol, 2000, 297, 1-6. [DOI no: 10.1006/jmbi.2000.3553]
PubMed id 10704302
Abstract
Endostatin is a proteolytic fragment of collagen XVIII that potently inhibits angiogenesis and tumour growth. Human endostatin contains a zinc ion, bound near the N terminus, which was not observed in the original structure of mouse endostatin at pH 5. Controversial data exist on the role of this zinc ion in the anti-tumour activity. We report two new crystal structures of mouse endostatin at pH 8.5 with bound zinc. One crystal form shows a metal ion coordination similar to that in human endostatin (His132, His134, His142, Asp207), but the conformation of the N-terminal segment is different. In the other crystal form, Asp136 replaces His132 as a zinc ligand. Site-directed mutagenesis of zinc-binding residues demonstrates that both coordination geometries occur in solution. The large degree of structural heterogeneity of the zinc-binding site has implications for endostatin function. We conclude that zinc is likely to play a structural rather than a critical functional role in endostatin.
Figure 1.
Figure 1. (2F[obs] -F[calc]), a[calc] simulated annealing omit maps of the region around the zinc-binding site in (a) mouse endostatin crystal form II and (b) crystal form III. Residues up to His142 and the zinc ion were excluded from the phasing model. The final refined models are shown superimposed on the maps. The zinc ion is shown as a pink sphere. Residues coordinating to the zinc ion have been labelled and metal-ligand bonds are shown as black sticks. Made with BOBSCRIPT (Kraulis 1991 and Esnouf 1997) and Raster3D (Merrit & Murphy, 1994).
Figure 2.
Figure 2. (a) Alignment of the N-terminal sequences of mouse and human endostatin. Residues added by the cloning process are in grey. Zinc-binding residues are marked by filled circles. (b) Comparison of the crystal structures of mouse endostatin forms II and III (in blue and green, respectively) and human endostatin (Ding et al., 1998; in pink). The structures were superimposed on residues 142-310 (mouse numbering scheme; Hohenester et al., 1998). The zinc ions are shown as spheres. The side-chains of His132, His134, and Asp136 are shown for all three structures; the side-chains of His142 and Asp207 are in almost identical positions in the three structures (see the text) and are shown only for mouse endostatin form II. Made with BOBSCRIPT (Kraulis 1991 and Esnouf 1997) and Raster3D (Merrit & Murphy, 1994).
The above figures are reprinted by permission from Elsevier: J Mol Biol (2000, 297, 1-6) copyright 2000.
Secondary reference #1
Title Crystal structure of the angiogenesis inhibitor endostatin at 1.5 a resolution.
Authors E.Hohenester, T.Sasaki, B.R.Olsen, R.Timpl.
Ref. EMBO J, 1998, 17, 1656-1664. [DOI no: 10.1093/emboj/17.6.1656]
PubMed id 9501087
Full text Abstract
Figure 2.
Figure 2 Stereo view of the final 2F[obs]-F[calc] map at 1.5 Å resolution. The region around -strand P is shown, with the disulphide bond between Cys164 and Cys304 in the centre. The map is contoured at the 1.5 level and is shown with the refined model superimposed. The figure was made with BOBSCRIPT (R.Esnouf, personal communication), a modified version of MOLSCRIPT (Kraulis, 1991).
Figure 5.
Figure 5 Electrostatic surface representation (Nicholls, 1992) of endostatin. The two views of the endostatin surface are related by a rotation of 130° about the horizontal axis. Blue indicates regions of positive potential and red regions of negative potential, at the 5 kT/e level. The N- and the C-termini are indicated; basic residues and the solvent-exposed side chains of Phe162 and Phe165 are labelled in yellow and white, respectively. The hatched area corresponds to the oligosaccharide-binding site of C-type lectin CRDs.
The above figures are reproduced from the cited reference which is an Open Access publication published by Macmillan Publishers Ltd
PROCHECK
Go to PROCHECK summary
 Headers

 

spacer

spacer